THYROCARE — Thyrocare Technologies Income Statement
0.000.00%
Last trade - 00:00
- IN₹47.64bn
- IN₹46.58bn
- IN₹5.72bn
- 98
- 14
- 95
- 84
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,332 | 4,946 | 5,889 | 5,267 | 5,719 |
Cost of Revenue | |||||
Gross Profit | 3,146 | 3,295 | 4,164 | 3,600 | 4,011 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,992 | 3,519 | 3,857 | 4,445 | 4,802 |
Operating Profit | 1,340 | 1,428 | 2,032 | 822 | 917 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,404 | 1,525 | 2,277 | 886 | 960 |
Provision for Income Taxes | |||||
Net Income After Taxes | 884 | 1,132 | 1,761 | 644 | 695 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 884 | 1,132 | 1,761 | 645 | 708 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 884 | 1,132 | 1,761 | 644 | 708 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 17.5 | 20.5 | 32.9 | 12.3 | 13.5 |
Dividends per Share |